Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Bulgaria54 clinical trials in Blagoevgrad, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on treatments for acute ischemic stroke and various forms of multiple sclerosis, including innovative therapies for both relapsing and progressive forms of MS.
Advanced clinical trials evaluating new therapeutic approaches for neurological conditions using targeted treatments and specialized medications.
Investigations into treatments for hypertriglyceridemia and various cardiovascular diseases, with studies focusing on lipid management and stroke prevention in atrial fibrillation.
Comprehensive research into metabolic disorders and cardiovascular health using innovative therapeutic approaches.
Clinical studies examining treatments for asthma, COPD, and respiratory infections, alongside research into immune system disorders.
Novel therapeutic approaches targeting both acute and chronic respiratory conditions with specialized medications.
Research into treatments for chronic kidney disease and related complications, including studies on anemia management and secondary hyperparathyroidism.
Comprehensive evaluation of long-term therapeutic solutions for chronic conditions affecting multiple body systems.
Tell us about your condition – we search every trial in Europe and connect you with the right site.